Application 021938

Type
NDA
Sponsor
CPPI CV

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SUTENTSUNITINIB MALATECAPSULE;ORALEQ 12.5MG BASEYesNo
002SUTENTSUNITINIB MALATECAPSULE;ORALEQ 25MG BASEYesNo
003SUTENTSUNITINIB MALATECAPSULE;ORALEQ 50MG BASEYesYes
004SUTENTSUNITINIB MALATECAPSULE;ORALEQ 37.5MG BASEYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0069-0550SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0550SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0550SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0550SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0550SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0550SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0550SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0550SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0550SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0770SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0770SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0770SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0770SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0770SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0770SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0770SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0770SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0770SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0830SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0830SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0830SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0830SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0830SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0830SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0830SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0830SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0830SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0980SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0980SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0980SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0980SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0980SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0980SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0980SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0980SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
0069-0980SUTENTSunitinib malatePfizer Laboratories Div Pfizer IncNDACurrent
63539-017SUTENTSunitinib malateU.S. PharmaceuticalsNDACurrent
63539-017SUTENTSunitinib malateU.S. PharmaceuticalsNDACurrent
63539-017SUTENTSunitinib malateU.S. PharmaceuticalsNDACurrent
63539-019SUTENTSunitinib malateU.S. PharmaceuticalsNDACurrent
63539-019SUTENTSunitinib malateU.S. PharmaceuticalsNDACurrent
63539-019SUTENTSunitinib malateU.S. PharmaceuticalsNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
68514SUPPL2021-09-02
68513SUPPL2021-09-02
68495SUPPL2021-08-31
64289SUPPL2020-08-17
64286SUPPL2020-08-17
64285SUPPL2020-08-17
63874SUPPL2020-07-13
63873SUPPL2020-07-13
63855SUPPL2020-07-13
58640SUPPL2019-05-13
58614SUPPL2019-05-08
58613SUPPL2019-05-08
57150SUPPL2019-01-09
56881SUPPL2018-12-20
50448SUPPL2017-11-17
50435SUPPL2017-11-16
37932SUPPL2015-11-19
28899SUPPL2015-11-17
37931SUPPL2015-04-28
16617SUPPL2015-04-28
28898SUPPL2015-04-27
6511SUPPL2015-04-27
37930SUPPL2014-12-23
6510SUPPL2014-12-23
6509SUPPL2014-06-12
37929SUPPL2013-09-09
16616SUPPL2013-09-09
28897SUPPL2013-09-04
28896SUPPL2013-09-04
37928SUPPL2012-11-19
37927SUPPL2012-11-19
28895SUPPL2012-11-19
16615SUPPL2012-11-19
6508SUPPL2012-11-19
6507SUPPL2012-11-19
37926SUPPL2012-04-24
28894SUPPL2012-04-24
16614SUPPL2012-04-24
6506SUPPL2012-04-24
28892SUPPL2011-05-25
6505SUPPL2011-05-25
6504SUPPL2011-05-25
43555SUPPL2011-05-20
37925SUPPL2011-05-20
37923SUPPL2011-05-20
16613SUPPL2011-05-20
37921SUPPL2010-09-22
37920SUPPL2010-09-22
28889SUPPL2010-09-22
16609SUPPL2010-09-22
6501SUPPL2010-09-22
6500SUPPL2010-09-22
43802ORIG2010-07-16
37924SUPPL2010-07-06
37922SUPPL2010-07-06
28893SUPPL2010-07-06
28891SUPPL2010-07-06
16612SUPPL2010-07-06
16611SUPPL2010-07-06
6503SUPPL2010-07-06
6502SUPPL2010-07-06
28890SUPPL2009-04-03
16610SUPPL2009-04-03
28888SUPPL2007-02-12
28887SUPPL2007-02-12
28886SUPPL2007-02-12
6499SUPPL2007-02-12
37919SUPPL2007-02-05
16608SUPPL2007-02-05
16607SUPPL2007-02-05
37918SUPPL2007-02-02
21880SUPPL2007-02-02
21879SUPPL2007-02-02
21878SUPPL2007-02-02
21877SUPPL2007-02-02
21876ORIG2006-04-06
28885ORIG2006-01-30
37917ORIG2006-01-26
66908ORIG1900-01-01
66907ORIG1900-01-01
63244SUPPL1900-01-01